Efficacy of fixed-dose combination artesunate-amodiaquine versus artemether-lumefantrine for uncomplicated childhood Plasmodium falciparum malaria in Democratic Republic of Congo: A randomized non-inferiority trial

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Espié, Emmanuelle ^a   Lima, Angeles ^b   Atua, Benjamin ^c   Dhorda, Mehul ^a   Flévaud, Laurence ^b   Sompwe, Eric M ^c   Palma Urrutia, Pedro Pablo ^b   Guerin, Philippe J ^a,d  

^a EPICENTRE   (France)

^b MÉDECINS SANS FRONTIÈRES   (Switzerland)

^c Ministry of Health   (Congo)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Artemether lumefantrine; Artesunate amodiaquine; Child; Treatment efficacy; Uncomplicated malaria

Indexed keywords

AMODIAQUINE PLUS ARTESUNATE; ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ASAQ WINTHROP; QUININE; UNCLASSIFIED DRUG; AMODIAQUINE; AMODIAQUINE, ARTESUNATE DRUG COMBINATION; ARTEMISININ DERIVATIVE; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE;

ABDOMINAL PAIN; ANEMIA; ARTICLE; CHILD; CHILDHOOD DISEASE; COMORBIDITY; CONGO; CONJUNCTIVITIS; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; INFANT; KAPLAN MEIER METHOD; LOADING DRUG DOSE; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALARIA; MALARIA FALCIPARUM; MALE; NONHUMAN; PARASITEMIA; PATIENT COMPLIANCE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TABLET FORMULATION; TREATMENT FAILURE; TREATMENT OUTCOME; VOMITING; CLASSIFICATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DEMOCRATIC REPUBLIC CONGO; DRUG COMBINATION; GENETICS; ISOLATION AND PURIFICATION; METHODOLOGY; PRESCHOOL CHILD;

AMODIAQUINE; ANTIMALARIALS; ARTEMISININS; CHILD, PRESCHOOL; DEMOCRATIC REPUBLIC OF THE CONGO; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FEMALE; FLUORENES; GENOTYPE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; PARASITEMIA; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; RECURRENCE; TREATMENT OUTCOME;

EID: 84861372005     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-174     Document Type: Article

References (32)

1. Estimating the global clinical burden of Plasmodium falciparum malaria in 2007. Hay SI, Okiro EA, Gething PW, Patil AP, Tatem AJ, Guerra CA, Snow RW, PLoS Med 2010 7 1000290 10.1371/journal.pmed.1000290 20563310
2. WHO, Malaria Control and Treatment in the Eastern Region of the Democratic Republic of the Congo (DRC) WHO, Geneva 2006 [ http://www.who.int/ hac/crises/cod/appeal/DRC-Malaria-control-east-Feb06.pdf ]
3. WHO, World malaria report 2009. Country Profile: Democratic Republic of Congo WHO, Geneva 2009b 96 98 [ http://whqlibdoc.who.int/publications/2009/ 9789241563901-eng-Profiles.pdf ]
4. dhfr and dhps genotype and sulfadoxine-pyrimethamine treatment failure in children with falciparum malaria in the Democratic Republic of Congo. Alker AP, Kazadi WM, Kutelemeni AK, Bloland PB, Tshefu AK, Meshnick SR, Trop Med Int Health 2008 13 1384 1391 10.1111/j.1365-3156.2008.02150.x 19055622 (Pubitemid 352672614)
5. WHO, Methods for surveillance of antimalarial drug efficacy WHO 2009 [ http://whqlibdoc.who.int/publications/2009/9789241597531-eng.pdf ]
6. Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes. Swarthout TB, Broek IV, Kayembe G, Pota H, Roper C, Trop Med Int Health 2006 11 1503 1511 10.1111/j.1365-3156.2006.01710.x 17002724 (Pubitemid 44450555)
7. Varying efficacy of artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in the Democratic Republic of Congo: a report of two in-vivo studies. Bonnet M, Broek I, van Herp M, Urrutia PP, van Overmeir C, Kyomuhendo J, Ndosimao CN, Ashley E, Guthmann JP, Malar J 2009 8 192 10.1186/1475-2875-8-192 19664280
8. World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs. Price RN, Dorsey G, Ashley EA, Barnes KI, Baird JK, d'Alessandro U, Guerin PJ, Laufer MK, Naidoo I, Nosten F, Olliaro P, Plowe CV, Ringwald P, Sibley CH, Stepniewska K, White NJ, Malar J 2007 6 119 10.1186/1475-2875-6-119 17822532 (Pubitemid 47561493)
9. Impact of transmission intensity on the accuracy of genotyping to distinguish recrudescence from new infection in antimalarial clinical trials. Greenhouse B, Dokomajilar C, Hubbard A, Rosenthal PJ, Dorsey G, Antimicrob Agents Chemother 2007 51 9 3096 3103 10.1128/AAC.00159-07 17591848 (Pubitemid 350067514)
10. The use of genotyping in antimalarial clinical trials: a systematic review of published studies from 1995-2005. Collins WJ, Greenhouse B, Rosenthal PJ, Dorsey G, Malar J 2006 5 122 10.1186/1475-2875-5-122 17169157 (Pubitemid 46020967)
11. Methods and techniques for clinical trials on antimalarial drug effi cacy: genotyping to identify parasite populations: informal consultation organized by the Medicines for Malaria Venture and cosponsored by the World Health Organization, 29-31 May 2007, Amsterdam, The Netherlands WHO [ http://whqlibdoc.who.int/publications/2008/9789241596305-eng.pdf ]
12. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Mårtensson A, Strömberg J, Sisowath C, Msellem MI, Gil JP, Montgomery SM, Olliaro P, Ali AS, Björkman A, Clin Infect Dis 2005 41 1079 1086 10.1086/444460 16163624 (Pubitemid 41429468)
13. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda. Yeka A, Dorsey G, Kamya MR, Talisuna A, Lugemwa M, Rwakimari JB, Staedke SG, Rosenthal PJ, Wabwire-Mangen F, Bukirwa H, PLoS One 2008 3 2390 10.1371/journal.pone.0002390 18545692
14. Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial. Zongo I, Dorsey G, Rouamba N, Tinto H, Dokomajilar C, Guiguemde RT, Rosenthal PJ, Ouedraogo JB, Lancet 2007 369 491 498 Erratum in: Lancet. 2007, 369:826 10.1016/S0140-6736(07)60236-0 17292769 (Pubitemid 46223467)
15. Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial. Ndiaye JL, Faye B, Gueye A, Tine R, Ndiaye D, Tchania C, Ndiaye I, Barry A, Cissé B, Lameyre V, Gaye O, Malar J 2011 10 237 10.1186/1475-2875-10-237 21838909
16. The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum. Sirima SB, Tiono AB, Gansané A, Diarra A, Ouédraogo A, Konaté AT, Kiechel JR, Morgan CC, Olliaro PL, Taylor WR, Malar J 2009 8 48 10.1186/1475-2875-8-48 19291301
17. The effect of varying analytical methods on estimates of anti-malarial clinical efficacy. Verret WJ, Dorsey G, Nosten F, Price RN, Malar J 2009 8 77 10.1186/1475-2875-8-77 19386088
18. Methodological issues in the assessment of antimalarial drug treatment: analysis of 13 studies in eight African countries from 2001 to 2004. Guthmann JP, Pinoges L, Checchi F, Cousens S, Balkan S, van Herp M, Legros D, Olliaro P, Antimicrob Agents Chemother 2006 50 3734 3739 10.1128/AAC.01618-05 16954313 (Pubitemid 44684888)
19. Different methodological approaches to the assessment of in vivo efficacy of three artemisinin-based combination antimalarial treatments for the treatment of uncomplicated falciparum malaria in African children. Ashley EA, Pinoges L, Turyakira E, Dorsey G, Checchi F, Bukirwa H, van den Broek I, Zongo I, Urruta PP, van Herp M, Balkan S, Taylor WR, Olliaro P, Guthmann JP, Malar J 2008 7 154 10.1186/1475-2875-7-154 18691429
20. Combination therapy for malaria: the way forward? Nosten F, Brasseur P, Drugs 2002 62 1325 1329
21. Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity. Stepniewska K, Price RN, Sutherland CJ, Drakeley CJ, von Seidlein L, Nosten F, White NJ, Malar J 2008 7 249 10.1186/1475-2875-7-249 19055751
22. Artemisinin resistance in Plasmodium falciparum malaria. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ, N Engl J Med 2009 361 455 467 Erratum in: N Engl J Med 2009, 361:1714 10.1056/NEJMoa0808859 19641202
23. Artemisinin Resistance in Cambodia 1 (ARC1) Study Consortium. Evidence of artemisinin-resistant malaria in western Cambodia. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, N Engl J Med 2008 359 2619 2620 10.1056/NEJMc0805011 19064625
24. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, Ler Moo C, Al-Saai S, Dondorp AM, Lwin KM, Singhasivanon P, Day NP, White NJ, Anderson TJ, Nosten F, Lancet 2012
25. In vivo parasitological measures of artemisinin susceptibility. Stepniewska K, Ashley E, Lee SJ, Anstey N, Barnes KI, Binh TQ, D'Alessandro U, Day NP, de Vries PJ, Dorsey G, Guthmann JP, Mayxay M, Newton PN, Olliaro P, Osorio L, Price RN, Rowland M, Smithuis F, Taylor WR, Nosten F, White NJ, J Infect Dis 2010 201 570 579 10.1086/650301 20085495
26. Use of weight-for-age-data to optimize tablet strength and dosing regimens for a new fixed-dose artesunate-amodiaquine combination for treating falciparum malaria. Taylor WR, Terlouw DJ, Olliaro PL, White NJ, Brasseur P, ter Kuile FO, Bull World Health Organ 2006 84 956 964 10.2471/BLT.06.031492 17242831 (Pubitemid 44901752)
27. Compliance, safety, and effectiveness of fixed-dose artesunate- amodiaquine for presumptive treatment of non severe malaria in the context of home management of malaria in Madagascar. Ratsimbasoa A, Ravony H, Vonimpaisomihanta JA, Raherinjafy R, Jahevitra M, Rapelanoro R, Rakotomanga Jde D, Malvy D, Millet P, Ménard D, AmJTrop Med Hyg 2012 86 203 210
28. Two-year evaluation of Intermittent Preventive Treatment for Children (IPTc) combined with timely home treatment for malaria control in Ghana. Ahorlu CK, Koram KA, Seake-Kwawu A, Weiss MG, Malar J 2011 10 127 10.1186/1475-2875-10- 127 21569634
29. Simplified antimalarial therapeutic monitoring: using the day-7 drug level? White NJ, Stepniewska K, Barnes K, Price RN, Simpson J, Trends Parasitol 2008 24 159 163 10.1016/j.pt.2008.01.006 18353727
30. WHO, Global report on antimalarial drug efficacy and drug resistance: 2000-2010 WHO, Geneva 2010 [http://whqlibdoc.who.int/publications/2010/ 9789241500470-eng.pdf]
31. Treating uncomplicated malaria in children: comparing artemisinin-based combination therapies. Yeka A, Harris JC, Curr Opin Pediatr 2010 22 798 803 10.1097/MOP.0b013e32833fac44 20844433
32. Do paediatric drug formulations of artemisinin combination therapies improve the treatment of children with malaria? A systematic review and meta-analysis. Kurth F, Bélard S, Adegnika AA, Gaye O, Kremsner PG, Ramharter M, Lancet Infect Dis 2010 10 125 132 10.1016/S1473-3099(09)70327-5 20113981